Able files for bankruptcy
Executive Summary
Able Labs files petition to reorganize under Chapter 11 in U.S. Bankruptcy Court in Trenton, N.J. The company is not currently generating revenue after manufacturing problems caused it to voluntarily suspend drug production and all product shipments in May (1"The Pink Sheet" May 23, 2005, p. 28)...
You may also be interested in...
Able Suspends Product Shipments Due To GMP Compliance Concerns
Able Laboratories is temporarily suspending shipment of all products until the company can guarantee the drugs have been manufactured in accordance with current good manufacturing practices, the company said May 19
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.